{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:23:07Z","timestamp":1761110587799},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T00:00:00Z","timestamp":1619222400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T00:00:00Z","timestamp":1619222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Genetic variants in the human leukocyte antigen (HLA) locus contribute to the risk for developing scleroderma\/systemic sclerosis (SSc). However, there are other replicated loci that also contribute to genetic risk for SSc, and it is unknown whether genetic risk in these non-HLA loci acts primarily on the vasculature, immune system, fibroblasts, or other relevant cell types. We used the Cistrome database to investigate the epigenetic landscapes surrounding 11 replicated SSc associated loci to determine whether SNPs in these loci may affect regulatory elements and whether they are likely to impact a specific cell type.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We mapped 11 replicated SNPs to haplotypes and sought to determine whether there was significant enrichment for H3K27ac and H3K4me1 marks, epigenetic signatures of enhancer function, on these haplotypes. We queried pathologically relevant cell types: B cells, endothelial cells, fibroblasts, monocytes, and T cells. We then identified the topologically associated domains (TADs) that encompass the SSc risk haplotypes in primary T cells to identify the full range of genes that may be influenced by SSc causal SNPs. We used gene ontology analyses of the genes within the TADs to gain insight into immunologic functions that might be affected by SSc causal SNPs.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The SSc-associated haplotypes were enriched (<jats:italic>p<\/jats:italic> value\u2009&lt;\u20090.01) for H3K4me1\/H3K27ac marks in monocytes. Enrichment of one of the two histone marks was found in B cells, fibroblasts, and T cells. No enrichment was identified in endothelial cells. Ontological analyses of genes within the TADs encompassing the risk haplotypes showed enrichment for regulation of transcription, protein binding, activation of T lymphocytes, and proliferation of immune cells.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The 11 non-HLA SSc risk haplotypes queried are highly enriched for H3K4me1\/H3K27ac-marked regulatory elements in a broad range of immune cells and fibroblasts. Furthermore, in immune cells, the risk haplotypes belong to larger chromatin structures encompassing genes that regulate a wide array of immune processes associated with SSc pathogenesis. Though importance of the vasculature in the pathobiology of SSc is widely accepted, we were unable to find evidence for genetic influences on endothelial cell function in these regions.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12920-021-00964-5","type":"journal-article","created":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T11:03:09Z","timestamp":1619262189000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Broadening our understanding of genetic risk for scleroderma\/systemic sclerosis by querying the chromatin architecture surrounding the risk haplotypes"],"prefix":"10.1186","volume":"14","author":[{"given":"Kerry E.","family":"Poppenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent M.","family":"Tutino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan","family":"Tarbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James N.","family":"Jarvis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,24]]},"reference":[{"issue":"4","key":"964_CR1","doi-asserted-by":"publisher","first-page":"221","DOI":"10.5114\/reum.2019.87619","volume":"57","author":"P Sobolewski","year":"2019","unstructured":"Sobolewski P, Ma\u015bli\u0144ska M, Wieczorek M, \u0141agun Z, Malewska A, Roszkiewicz M, et al. Systemic sclerosis\u2014multidisciplinary disease: clinical features and treatment. Reumatologia. 2019;57(4):221\u201333.","journal-title":"Reumatologia"},{"issue":"2","key":"964_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/ar628","volume":"5","author":"KT Ho","year":"2003","unstructured":"Ho KT, Reveille JD. The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther. 2003;5(2):80\u201393.","journal-title":"Arthritis Res Ther"},{"issue":"suppl_3","key":"964_CR3","first-page":"iii33","volume":"45","author":"C Sunderk\u00f6tter","year":"2006","unstructured":"Sunderk\u00f6tter C, Riemekasten G. Pathophysiology and clinical consequences of Raynaud\u2019s phenomenon related to systemic sclerosis. Rheumatology. 2006;45(suppl_3):iii33\u20135.","journal-title":"Rheumatology"},{"issue":"6","key":"964_CR4","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1136\/ard.2006.062901","volume":"66","author":"UA Walker","year":"2007","unstructured":"Walker UA, Tyndall A, Czirj\u00e1k L, Denton C, Farge-Bancel D, Kowal-Bielecka O, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis. 2007;66(6):754.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"964_CR5","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1002\/art.37988","volume":"65","author":"M Matucci-Cerinic","year":"2013","unstructured":"Matucci-Cerinic M, Kahaleh B, Wigley FM. Review: evidence that systemic sclerosis is a vascular disease. Arthritis Rheum. 2013;65(8):1953\u201362.","journal-title":"Arthritis Rheum"},{"key":"964_CR6","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3389\/fimmu.2015.00272","volume":"6","author":"D Pattanaik","year":"2015","unstructured":"Pattanaik D, Brown M, Postlethwaite BC, Postlethwaite AE. Pathogenesis of systemic sclerosis. Front Immunol. 2015;6:272.","journal-title":"Front Immunol"},{"issue":"8","key":"964_CR7","first-page":"1481","volume":"32","author":"DD Gladman","year":"2005","unstructured":"Gladman DD, Kung TN, Siannis F, Pellett F, Farewell VT, Lee P. HLA markers for susceptibility and expression in scleroderma. J Rheumatol. 2005;32(8):1481.","journal-title":"J Rheumatol"},{"issue":"3","key":"964_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11926-014-0484-x","volume":"17","author":"BD Korman","year":"2015","unstructured":"Korman BD, Criswell LA. Recent advances in the genetics of systemic sclerosis: toward biological and clinical significance. Curr Rheumatol Rep. 2015;17(3):21.","journal-title":"Curr Rheumatol Rep"},{"issue":"12","key":"964_CR9","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1002\/art.24982","volume":"60","author":"X Zhou","year":"2009","unstructured":"Zhou X, Lee JE, Arnett FC, Xiong M, Park MY, Yoo YK, et al. HLA\u2013DPB1 and DPB2 are genetic loci for systemic sclerosis: a genome-wide association study in Koreans with replication in North Americans. Arthritis Rheum. 2009;60(12):3807\u201314.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"964_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.rdc.2007.10.001","volume":"34","author":"S Agarwal","year":"2008","unstructured":"Agarwal S, Tan F, Arnett F. Genetics and genomic studies in scleroderma (systemic sclerosis). Rheum Dis Clin N Am. 2008;34(1):17.","journal-title":"Rheum Dis Clin N Am"},{"issue":"5","key":"964_CR11","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1136\/ard.2009.111906","volume":"69","author":"FC Arnett","year":"2010","unstructured":"Arnett FC, Gourh P, Shete S, Ahn CW, Honey RE, Agarwal SK, et al. Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African\u2013American and Hispanic cases and 1000 controls. Ann Rheum Dis. 2010;69(5):822.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"964_CR12","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/ng.565","volume":"42","author":"TRDJ Radstake","year":"2010","unstructured":"Radstake TRDJ, Gorlova O, Rueda B, Martin J-E, Alizadeh BZ, Palomino-Morales R, et al. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet. 2010;42(5):426\u20139.","journal-title":"Nat Genet"},{"issue":"7","key":"964_CR13","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1002\/art.39135","volume":"67","author":"K Jiang","year":"2015","unstructured":"Jiang K, Zhu L, Buck MJ, Chen Y, Carrier B, Liu T, et al. Disease-associated SNPs from non-coding regions in Juvenile idiopathic arthritis are located within or adjacent to functional genomic elements of human neutrophils and CD4+ T Cells. Arthritis Rheumatol (Hoboken, NJ). 2015;67(7):1966\u201377.","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"issue":"1","key":"964_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s13075-016-1169-9","volume":"18","author":"JS Hui-Yuen","year":"2016","unstructured":"Hui-Yuen JS, Zhu L, Wong LP, Jiang K, Chen Y, Liu T, et al. Chromatin landscapes and genetic risk in systemic lupus. Arthritis Res Ther. 2016;18(1):281.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"964_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12920-019-0591-7","volume":"12","author":"KE Poppenberg","year":"2019","unstructured":"Poppenberg KE, Jiang K, Tso MK, Snyder KV, Siddiqui AH, Kolega J, et al. Epigenetic landscapes suggest that genetic risk for intracranial aneurysm operates on the endothelium. BMC Med Genom. 2019;12(1):149.","journal-title":"BMC Med Genom"},{"issue":"7539","key":"964_CR16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature13835","volume":"518","author":"KK-H Farh","year":"2015","unstructured":"Farh KK-H, Marson A, Zhu J, Kleinewietfeld M, Housley WJ, Beik S, et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature. 2015;518(7539):337\u201343.","journal-title":"Nature"},{"issue":"1","key":"964_CR17","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1038\/s41467-018-05328-9","volume":"9","author":"RC Pelikan","year":"2018","unstructured":"Pelikan RC, Kelly JA, Fu Y, Lareau CA, Tessneer KL, Wiley GB, et al. Enhancer histone-QTLs are enriched on autoimmune risk haplotypes and influence gene expression within chromatin networks. Nat Commun. 2018;9(1):2905.","journal-title":"Nat Commun"},{"issue":"8","key":"964_CR18","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1093\/bioinformatics\/btu779","volume":"31","author":"M Arnold","year":"2014","unstructured":"Arnold M, Raffler J, Pfeufer A, Suhre K, Kastenm\u00fcller G. SNiPA: an interactive, genetic variant-centered annotation browser. Bioinformatics. 2014;31(8):1334\u20136.","journal-title":"Bioinformatics"},{"issue":"7","key":"964_CR19","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1002\/art.39135","volume":"67","author":"K Jiang","year":"2015","unstructured":"Jiang K, Zhu L, Buck MJ, Chen Y, Carrier B, Liu T, et al. Disease-associated SNPs from non-coding regions in juvenile idiopathic arthritis are located within or adjacent to functional genomic elements of human neutrophils and CD4+ T cells. Arthritis Rheumatol. 2015;67(7):1966\u201377.","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"964_CR20","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.cell.2016.10.024","volume":"167","author":"D Hnisz","year":"2016","unstructured":"Hnisz D, Day DS, Young RA. Insulated neighborhoods: structural and functional units of mammalian gene control. Cell. 2016;167(5):1188\u2013200.","journal-title":"Cell"},{"key":"964_CR21","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.3389\/fimmu.2018.02964","volume":"9","author":"H Kessler","year":"2018","unstructured":"Kessler H, Jiang K, Jarvis JN. Using chromatin architecture to understand the genetics and transcriptomics of juvenile idiopathic arthritis. Front Immunol. 2018;9:2964.","journal-title":"Front Immunol"},{"issue":"1","key":"964_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.cell.2018.11.029","volume":"176","author":"M Gasperini","year":"2019","unstructured":"Gasperini M, Hill AJ, McFaline-Figueroa JL, Martin B, Kim S, Zhang MD, et al. A genome-wide framework for mapping gene regulation via cellular genetic screens. Cell. 2019;176(1):377-90.e19.","journal-title":"Cell"},{"key":"964_CR23","doi-asserted-by":"crossref","unstructured":"Tarbell EJK, Hennon TR, Holmes L, Williams S, Fu Y, Gaffney PM, Liu T, Jarvis JN. CD4+ T cells from children with active juvenile idiopathic arthritis show altered chromatin features associated with transcriptional abnormalities. Sci Rep. 2021 (in press).","DOI":"10.1038\/s41598-021-82989-5"},{"issue":"1","key":"964_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.cels.2015.07.012","volume":"3","author":"NC Durand","year":"2016","unstructured":"Durand NC, Robinson JT, Shamim MS, Machol I, Mesirov JP, Lander ES, et al. Juicebox provides a visualization system for Hi-C contact maps with unlimited zoom. Cell Syst. 2016;3(1):99\u2013101.","journal-title":"Cell Syst"},{"key":"964_CR25","doi-asserted-by":"crossref","unstructured":"Phanstiel DH, Van Bortle K, Spacek D, Hess GT, Shamim MS, Machol I, et al. Static and dynamic DNA loops form AP-1 bound activation hubs during macrophage development. bioRxiv. 2017:142026.","DOI":"10.1101\/142026"},{"key":"964_CR26","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1471-2105-10-48","volume":"10","author":"E Eden","year":"2009","unstructured":"Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z. GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinform. 2009;10:48.","journal-title":"BMC Bioinform"},{"issue":"7","key":"964_CR27","doi-asserted-by":"publisher","first-page":"e21800-e","DOI":"10.1371\/journal.pone.0021800","volume":"6","author":"F Supek","year":"2011","unstructured":"Supek F, Bo\u0161njak M, \u0160kunca N, \u0160muc T. REVIGO summarizes and visualizes long lists of gene ontology terms. PLoS ONE. 2011;6(7):e21800-e.","journal-title":"PLoS ONE"},{"issue":"4","key":"964_CR28","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kr\u00e4mer","year":"2014","unstructured":"Kr\u00e4mer A, Green J, Pollard J Jr, Tugendreich S. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics (Oxford, England). 2014;30(4):523\u201330.","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"6099","key":"964_CR29","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1126\/science.1222794","volume":"337","author":"MT Maurano","year":"2012","unstructured":"Maurano MT, Humbert R, Rynes E, Thurman RE, Haugen E, Wang H, et al. Systematic localization of common disease-associated variation in regulatory DNA. Science (New York, NY). 2012;337(6099):1190\u20135.","journal-title":"Science (New York, NY)"},{"key":"964_CR30","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.3389\/fimmu.2018.03112","volume":"9","author":"ATJ Maria","year":"2019","unstructured":"Maria ATJ, Partouche L, Goulabchand R, Rivi\u00e8re S, Rozier P, Bourgier C, et al. Intriguing relationships between cancer and systemic sclerosis: role of the immune system and other contributors. Front Immunol. 2019;9:3112.","journal-title":"Front Immunol"},{"key":"964_CR31","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3389\/fimmu.2018.00449","volume":"9","author":"M Dolcino","year":"2018","unstructured":"Dolcino M, Pelosi A, Fiore PF, Patuzzo G, Tinazzi E, Lunardi C, et al. Gene profiling in patients with systemic sclerosis reveals the presence of oncogenic gene signatures. Front Immunol. 2018;9:449.","journal-title":"Front Immunol"},{"issue":"6","key":"964_CR32","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1053\/sarh.2001.20269","volume":"30","author":"W Grassi","year":"2001","unstructured":"Grassi W, Medico PD, Izzo F, Cervini C. Microvascular involvement in systemic sclerosis: capillaroscopic findings. Semin Arthritis Rheum. 2001;30(6):397\u2013402.","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"964_CR33","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0190-9622(80)80396-3","volume":"2","author":"R Fleischmajer","year":"1980","unstructured":"Fleischmajer R, Perlish JS. Capillary alterations in scleroderma. J Am Acad Dermatol. 1980;2(2):161\u201370.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"964_CR34","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1097\/01.bor.0000139310.77347.9c","volume":"16","author":"AE Postlethwaite","year":"2004","unstructured":"Postlethwaite AE, Shigemitsu H, Kanangat S. Cellular origins of fibroblasts: possible implications for organ fibrosis in systemic sclerosis. Curr Opin Rheumatol. 2004;16(6):733\u20138.","journal-title":"Curr Opin Rheumatol"},{"key":"964_CR35","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nri3671","volume":"14","author":"F Ginhoux","year":"2014","unstructured":"Ginhoux F, Jung S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat Rev Immunol. 2014;14:392\u2013404 (1474-1741 (Electronic)).","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"964_CR36","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10753-008-9078-y","volume":"31","author":"M Katebi","year":"2008","unstructured":"Katebi M, Fernandez P, Chan ESL, Cronstein BN. Adenosine A2A receptor blockade or deletion diminishes fibrocyte accumulation in the skin in a murine model of scleroderma, bleomycin-induced fibrosis. Inflammation. 2008;31(5):299\u2013303.","journal-title":"Inflammation"},{"issue":"4","key":"964_CR37","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.biocel.2003.10.005","volume":"36","author":"TE Quan","year":"2004","unstructured":"Quan TE, Cowper S, Wu S-P, Bockenstedt LK, Bucala R. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol. 2004;36(4):598\u2013606.","journal-title":"Int J Biochem Cell Biol"},{"issue":"6","key":"964_CR38","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/labinvest.2010.73","volume":"90","author":"SK Mathai","year":"2010","unstructured":"Mathai SK, Gulati M, Peng X, Russell TR, Shaw AC, Rubinowitz AN, et al. Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Lab Investig. 2010;90(6):812\u201323.","journal-title":"Lab Investig"},{"issue":"6","key":"964_CR39","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S2213-2600(18)30508-3","volume":"7","author":"MKD Scott","year":"2019","unstructured":"Scott MKD, Quinn K, Li Q, Carroll R, Warsinske H, Vallania F, et al. Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study. Lancet Respir Med. 2019;7(6):497\u2013508.","journal-title":"Lancet Respir Med"},{"issue":"6","key":"964_CR40","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.mayocp.2015.03.025","volume":"90","author":"T Tadmor","year":"2015","unstructured":"Tadmor T, Bari A, Marcheselli L, Sacchi S, Aviv A, Baldini L, et al. Absolute monocyte count and lymphocyte-monocyte ratio predict outcome in nodular sclerosis Hodgkin lymphoma: evaluation based on data from 1450 patients. Mayo Clin Proc. 2015;90(6):756\u201364.","journal-title":"Mayo Clin Proc"},{"key":"964_CR41","doi-asserted-by":"publisher","first-page":"e21856","DOI":"10.7554\/eLife.21856","volume":"6","author":"PJ Skene","year":"2017","unstructured":"Skene PJ, Henikoff S. An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites. Elife. 2017;6:e21856.","journal-title":"Elife"},{"issue":"3","key":"964_CR42","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1093\/nar\/gkz1102","volume":"48","author":"S Zhang","year":"2020","unstructured":"Zhang S, Chen F, Bahar I. Differences in the intrinsic spatial dynamics of the chromatin contribute to cell differentiation. Nucleic Acids Res. 2020;48(3):1131\u201345.","journal-title":"Nucleic Acids Res"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-021-00964-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-021-00964-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-021-00964-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T11:03:19Z","timestamp":1619262199000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-021-00964-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,24]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["964"],"URL":"https:\/\/doi.org\/10.1186\/s12920-021-00964-5","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,24]]},"assertion":[{"value":"5 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KEP\u2014None. VMT\u2014Principal investigator: National Science Foundation Award No. 1746694 and NIH NINDS award R43 NS115314-0. Awardee of the abovementioned Brain Aneurysm Foundation grant, Center for Advanced Technology grant, and Cummings Foundation grant. Co-founder: Neurovascular Diagnostics, Inc. ET\u2014Assistant Director at Quantitative Systems Pharmacology, Enhanced Pharmacodynamics, LLC, JNJ\u2014Principal Investigator: R21-AR071878.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}